Manfred Gerken

Title: Manfred Gerken: Innovator in Peptide Chemistry

Introduction

Manfred Gerken, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of peptide chemistry. With two registered patents, his work centers on innovative methods that enhance the efficiency and effectiveness of peptide synthesis.

Latest Patents

Gerken's most recent patents showcase his expertise in the development of techniques for the cleavage and synthesis of polypeptides. The first patent, titled "Method for cleavage of solid phase-bound peptides from the solid phase," outlines a procedure that involves treating solid-phase-bound polypeptides with a specific combination of trifluoroacetic acid and 1,2-ethanedithiol, under controlled temperature conditions. This method represents a notable advancement in peptide purification technology.

The second patent, "Capping of unprotected amino groups during peptide synthesis," describes a multi-step process for synthesizing polypeptides with predetermined amino acid sequences. This innovative approach includes coupling, capping, and de-protecting steps, which streamline the synthesis process and improve the quality of the resulting peptides.

Career Highlights

Gerken's professional journey has been significantly shaped by his association with Sanofi-Aventis Deutschland GmbH, a company recognized for its commitment to advancing medical research and pharmaceutical development. His role at the company has allowed him to apply his skills in peptide chemistry effectively, contributing to various projects that drive innovation in the field.

Collaborations

Throughout his career, Manfred Gerken has collaborated with fellow researchers, including Bernd Henkel and Wolfgang Fiedler. These partnerships underscore the importance of teamwork in scientific discovery and development, facilitating the sharing of ideas and expertise which ultimately leads to groundbreaking inventions.

Conclusion

Manfred Gerken stands out as a prominent inventor in peptide chemistry, with two patents that highlight his innovative methodologies for peptide synthesis and cleavage. His ongoing work at Sanofi-Aventis Deutschland GmbH and collaborations with esteemed colleagues signify his commitment to pushing the boundaries of scientific research. As the field of peptide chemistry continues to evolve, Gerken's contributions will likely play a pivotal role in shaping future advancements.